Statistics for CCL26-targeted siRNA treatment of alveolar type II cells decreases expression of CCR3-binding chemokines and reduces eosinophil migration: implications in asthma therapy
Total visits
| views | |
|---|---|
| CCL26-targeted siRNA treatment of alveolar type II cells decreases expression of CCR3-binding chemokines and reduces eosinophil migration: implications in asthma therapy | 0 |
Total visits per month
| views | |
|---|---|
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
File Visits
| views | |
|---|---|
| Abonyo_CCL26-targeted siRNA treatment of alveolar type II cells decreases expression_compressed.pdf | 62 |
| Abonyo_CCL26-targeted siRNA treatment of alveolar type II cells decreases expression of CCR3-binding chemokines and reduces eosinophil migration implications in asthma therapy.pdf.pdf | 2 |
| Abonyo_CCL26-targeted siRNA treatment of alveolar type II cells decreases expression.pdf | 1 |